The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects who are at least 18 years old and who are indicated for a VVI(R) pacemaker
Subject must have one of the following clinical indications: Chronic atrial fibrillation with 2 or 3° AV or bifascicular bundle branch block (BBB block) ; or Normal sinus rhythm with 2º or 3° AV or BBB block and a low level of physical activity or short expected lifespan (but at least one year); or Sinus bradycardia with infrequent pauses or unexplained syncope with EP findings; and
Subject ≥18 years of age; and
Subject has life expectancy of at least one year and is a suitable candidate based on overall health and well-being; and
Subject is not enrolled in another clinical investigation with a treatment arm or that could confound the results of this study; and
Subject is willing to comply with clinical investigation procedures and agrees to return for all required follow-up visits, tests, and exams; and
Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent, approved by the EC; and
Subject is not pregnant and does not plan on getting pregnant during the course of the study.
Known pacemaker syndrome, have retrograde VA conduction or suffer a drop in arterial blood pressure with the onset of ventricular pacing; or
Hypersensitivity to < 1 mg of dexamethasone sodium phosphate; or
Mechanical tricuspid valve prosthesis; or
Pre-existing pulmonary arterial (PA) hypertension (PA systolic pressure exceeds 40mmHg or RV systolic pressure (RVSP) as estimated by echo exceeds 40mmHg) or significant physiologically-impairing lung disease (has severe pulmonary disease producing frequent hospitalization for respiratory distress or requiring continuous home oxygen); or
Pre-existing ventricular pacing or defibrillation leads; or
Current implantation of either conventional or subcutaneous implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT); or
Presence of implanted vena cava filter; or
Evidence of thrombosis in one of the veins used for access during the procedure; or
Cardiovascular or peripheral vascular surgery/intervention within 30 days of enrolment; or